Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering NCGC00024964-02.

Client Email

Product

NCGC00024964-02
HEALTH CANADA PATENTS

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Fulvestrant

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

NCGC00024964-02

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

40 API Suppliers, 15 USDMF, 9 CEP/COS, 2 JDMF, 1 EU WC, 5 KDMF, 12 NDC API, 27 Listed Suppliers, $ API Reference Price

40 API Suppliers
15 USDMF
9 CEP/COS
2 JDMF
1 EU WC
5 KDMF
12 NDC API
27 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

86 Drugs in Development

86 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Imports

INTERMEDIATES

7 API Suppliers

7 API Suppliers

FINISHED DOSAGE FORMULATIONS

63 FDF Dossiers, 19 FDA Orange Book, 13 Europe, 6 Canada, 3 Australia, 8 South Africa, 14 Listed Dossiers

63 FDF Dossiers
19 FDA Orange Book
13 Europe
6 Canada
3 Australia
8 South Africa
14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAMUSCULAR - 125MG/2.5ML (50MG/ML), SOLUTION;INTRAMUSCULAR - 250MG/5ML (50MG/ML)

SOLUTION;INTRAMUSCULAR - 125MG/2.5ML (50MG/ML)
SOLUTION;INTRAMUSCULAR - 250MG/5ML (50MG/ML)

RELATED EXCIPIENT COMPANIES

2 Nanjing Well Pharmaceutical, 1 Actylis, 2 Finar, 1 TopChem Pharmaceuticals

2 Nanjing Well Pharmaceutical
1 Actylis
2 Finar
1 TopChem Pharmaceuticals

EXCIPIENTS BY APPLICATIONS

3 Topical, 3 Parenteral, 1 Solubilizers

3 Topical
3 Parenteral
1 Solubilizers

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 99 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
99 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 11 Finished Drug Prices, 10 Annual Reports

2 US Medicaid Prescriptions
11 Finished Drug Prices
10 Annual Reports

MARKET PLACE

5 APIs, 8 FDF Dossiers

5 APIs
8 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents, 1 Health Canada Patents

3 US Patents
1 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 4 Others

2 EDQM
2 USP
4 Others

$ API Ref.Price (USD/KG) : 49,217 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

1 All

01 1AstraZeneca Canada Inc.

filter Patent Reset all filters

1 All

01 12351004

filter Product Reset all filters

1 All

01 1Fulvestrant

filter Dosage Reset all filters

1 All

01 1Injectable Solution

filter Exp Date Reset all filters

1 All

01 12021-01-08

US Patents
Health Canada Patents

Product Main Page

01

AstraZeneca Canada Inc.

Fulvestrant

Formnext Forum

Not Confirmed

AstraZeneca Canada Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-01-08

Date Granted : 2003-02-18

Fulvestrant

Brand Name : FASLODEX

Patent Number : 2351004

Filing Date : 2001-01-08

Strength per Unit : 50 mg / mL

Dosage Form : Injectable Solution

Human Or VET : Human

Route of Administration : Intramuscular Injection

Patent Expiration Date : 2021-01-08

Date Granted : 2003-02-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?